SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-024560
Filing Date
2024-05-21
Accepted
2024-05-21 17:08:39
Documents
76
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hepa-20240331.htm   iXBRL 10-Q 776684
2 EX-31.1 hepa-q1202410xqxexx311.htm EX-31.1 9808
3 EX-31.2 hepa-q1202410xqxexx312.htm EX-31.2 9676
4 EX-32.1 hepa-q1202410xqxexx321.htm EX-32.1 4659
5 EX-32.2 hepa-q1202410xqxexx322.htm EX-32.2 4646
11 hepa-20240331_g1.jpg GRAPHIC 10809
  Complete submission text file 0001628280-24-024560.txt   5392300

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hepa-20240331.xsd EX-101.SCH 39585
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hepa-20240331_cal.xml EX-101.CAL 42473
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hepa-20240331_def.xml EX-101.DEF 218959
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hepa-20240331_lab.xml EX-101.LAB 523449
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hepa-20240331_pre.xml EX-101.PRE 394654
79 EXTRACTED XBRL INSTANCE DOCUMENT hepa-20240331_htm.xml XML 657052
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 24970579
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)